Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Güthle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Visceral Medicine|August 11, 2020
Immunotherapy in Gastrointestinal CancersMelanie Güthle, Thomas Ettrich, Thomas Seufferlein
Zeitschrift Fur Gastroenterologie|March 22, 2021
A comparison of spleen size measured by ultrasound in a random population sample and a matched sample of patients at a university hospital, and the determination of normal values and influencing factorsTheresa Schranz, Jochen Klaus, Wolfgang Kratzer, et al.
Visceral Medicine|March 17, 2022
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological ProfilingThomas J Ettrich, Niklas Sturm, Melanie Güthle, et al.
Quantitative Imaging in Medicine and Surgery|March 14, 2022
Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot studyWolfgang Kratzer, Melanie Güthle, Felix Dobler, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Visceral Medicine|August 11, 2020
Immunotherapy in Gastrointestinal CancersMelanie Güthle, Thomas Ettrich, Thomas Seufferlein
Zeitschrift Fur Gastroenterologie|March 22, 2021
A comparison of spleen size measured by ultrasound in a random population sample and a matched sample of patients at a university hospital, and the determination of normal values and influencing factorsTheresa Schranz, Jochen Klaus, Wolfgang Kratzer, et al.
Visceral Medicine|March 17, 2022
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological ProfilingThomas J Ettrich, Niklas Sturm, Melanie Güthle, et al.
Quantitative Imaging in Medicine and Surgery|March 14, 2022
Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot studyWolfgang Kratzer, Melanie Güthle, Felix Dobler, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
Pageof 1